1. Home
  2. LAB vs INV Comparison

LAB vs INV Comparison

Compare LAB & INV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAB
  • INV
  • Stock Information
  • Founded
  • LAB 1999
  • INV 2015
  • Country
  • LAB United States
  • INV United States
  • Employees
  • LAB N/A
  • INV N/A
  • Industry
  • LAB Biotechnology: Laboratory Analytical Instruments
  • INV
  • Sector
  • LAB Industrials
  • INV
  • Exchange
  • LAB Nasdaq
  • INV NYSE
  • Market Cap
  • LAB 562.1M
  • INV 363.2M
  • IPO Year
  • LAB 2011
  • INV N/A
  • Fundamental
  • Price
  • LAB $1.09
  • INV $6.60
  • Analyst Decision
  • LAB Strong Buy
  • INV Strong Buy
  • Analyst Count
  • LAB 3
  • INV 2
  • Target Price
  • LAB $2.88
  • INV $14.00
  • AVG Volume (30 Days)
  • LAB 1.5M
  • INV 40.7K
  • Earning Date
  • LAB 05-07-2025
  • INV 05-15-2025
  • Dividend Yield
  • LAB N/A
  • INV N/A
  • EPS Growth
  • LAB N/A
  • INV N/A
  • EPS
  • LAB N/A
  • INV N/A
  • Revenue
  • LAB $174,432,000.00
  • INV $988,000.00
  • Revenue This Year
  • LAB N/A
  • INV $2,784.42
  • Revenue Next Year
  • LAB $12.77
  • INV $215.34
  • P/E Ratio
  • LAB N/A
  • INV N/A
  • Revenue Growth
  • LAB 64.03
  • INV 4.88
  • 52 Week Low
  • LAB $0.99
  • INV $6.44
  • 52 Week High
  • LAB $3.04
  • INV $18.75
  • Technical
  • Relative Strength Index (RSI)
  • LAB 40.52
  • INV N/A
  • Support Level
  • LAB $1.05
  • INV N/A
  • Resistance Level
  • LAB $1.21
  • INV N/A
  • Average True Range (ATR)
  • LAB 0.07
  • INV 0.00
  • MACD
  • LAB 0.01
  • INV 0.00
  • Stochastic Oscillator
  • LAB 19.05
  • INV 0.00

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

About INV INNVENTURE INC

Innventure Inc creates, funds, operates, and rapidly scales companies in strategic collaboration with MNCs. It provides company creation, corporate strategy, technology optimization, operations, commercialization, and funding. Innventure analyzes the market, including proprietary data provided by MNCs, to identify where their well-protected, breakthrough technologies address market needs and have the potential to create $1B+ in new enterprise value.

Share on Social Networks: